Stock Taper
ALKS
ALKERMES PLC
NASDAQ
$47.41
▼ DOWN 3.05% (-1.49)

KEY STATISTICS

Market Cap$7.95 B
52w High$55.67
52w Low$25.17
Dividend Yield
Frequency
P/E49.91
Volume1.43M
Shares Out.167.76M

COMPANY

LEADERSHIP

Blair Jackson
CHIEF EXECUTIVE
Blair Jackson

COMPENSATION 2026

Salary$1,250,769
Stock Awards$0
Incentive Plan Pay$1,626,000
All Other Comp.$17,500
Total$7,915,081

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 16, 1991
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
2,050

PRICE TARGET

Target High$65.00
Target Low$54.00
Target Median$63.00
Target Consensus$60.60

UPCOMING EARNINGS

DateOct 28, 2026
DayWednesday
Rev. Est.$463.88M
OCT
28
WED

SPLIT RECORD

DATETYPERATIO
2000-05-15Forward2:1

PRICE

$47.41 ▼ DOWN 3.05% (−$1.49)
OVERLAYS
$47.50$48.00$48.509:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM47.41

About Alkermes plc

http://www.alkermes.com ↗

Alkermes plc is a biopharmaceutical company developing and commercializing treatments for mental health, addiction, and multiple sclerosis, with products like ARISTADA, VIVITROL, and VUMERITY, and collaborations with Janssen.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT ALKERMES PLC IS KNOWN FOR

LUMRYZ
LUMRYZ

LUMRYZ, an extended-release oral suspension for narcolepsy symptoms, was acquired by Alkermes in 2026 through Avadel Pharmaceuticals, marking a strategic entry into the sleep medicine market.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$317.42M $338.11M $411.72M
Manufactured Product And Royalty$229.24M
Vivitrol$121.13M $225.13M $112.43M $124.45M
Aristada And Aristada Initio$98.05M $170.7M $93.82M $96.72M
L Y B A L V I$98.25M $92.36M $93.98M

Revenue by Geography

MapREGIONFY2022FY2023FY2024FY2025
UNITED STATES$931.99M $1.49B $1.41B $1.37B
Foreign Country Excluding Specified Country$177.97M $170.29M $146.18M $102.36M
IRELAND$1.83M $1.18M $1.29M $754K

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity3
Return On Assets3
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

OFFICER: SVP, CHIEF COMMERCIAL OFFICER
Nichols Christian Todd
Sale · 664 shares
2026-08-17
OFFICER: SVP, CHIEF COMMERCIAL OFFICER
Nichols Christian Todd
Sale · 6.9K shares
2026-08-17
DIRECTOR, OFFICER: PRESIDENT & CEO, ALKERMES PLC
Jackson Blair Curtis
Purchase · 93.2K shares
2026-08-05
DIRECTOR, OFFICER: PRESIDENT & CEO, ALKERMES PLC
Jackson Blair Curtis
Purchase · 124.3K shares
2026-08-05

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 6
OUTPERFORM 3
NEUTRAL 2
OVERWEIGHT 2
UNDERPERFORM 1
14 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
ARWR$84.91COMPARE
KYMR$118.15COMPARE
PTGX$144.33COMPARE
PCVX$59.84COMPARE
TGTX$53.93COMPARE
PTCT$70.09COMPARE
CRSP$57.72COMPARE
ACAD$29.11COMPARE